Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Testosterone protects female heart cells from stress by activating estrogen receptors.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

17β-Estradiol slows wound healing in male mice through estrogen receptor-α.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Neurosteroids show promise for treating epilepsy and more research is needed.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Skin symptoms can indicate endocrine disorders and have various treatments.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

The link between anabolic agents and colorectal cancer risk is unclear.

Understanding genes and hormones is crucial for managing male puberty and sex development disorders.